Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

Clinical trial NCT07528768 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07528768
Sponsor: AntiCancer Research Jamaica
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer Metastatic Triple-negative Breast Cancer

Start date: 2026-06-01
Primary completion: 2034-06-01
Enrollment: 750

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.